Stocks Health care CGTX
NASDAQ · Health careCognition Therapeutics Inc (CGTX)
It posted a net loss of $16.8M. At June 30, 2026 it held $34M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 7, 2026.
What Cognition Therapeutics Inc does
Cognition Therapeutics Inc is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker CGTX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$23.5M | -$0.32 | n/a |
| 2024 | n/a | -$34M | -$0.86 | -$28.5M |
| 2023 | n/a | -$25.8M | -$0.86 | -$16.2M |
| 2022 | n/a | -$21.4M | -$0.91 | -$18.7M |
| 2021 | n/a | -$11.7M | -$3.13 | -$3.7M |
| 2021 | n/a | -$7.8M | -$23.76 | -$3.4M |
Latest SEC filings
What Cognition Therapeutics Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 7, 2026Quarterly report 10-Q · period to June 30, 2026
- August 6, 2026
- June 24, 2026Other event 8-K
- June 18, 2026
- June 4, 2026
- May 21, 2026Other event 8-K
- May 8, 2026Quarterly report 10-Q · period to March 31, 2026
- May 7, 2026
- April 27, 2026
- April 27, 2026Additional proxy material DEFA14A
Questions about CGTX
What does Cognition Therapeutics Inc do?
Cognition Therapeutics Inc is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker CGTX.
Is Cognition Therapeutics Inc profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $16.8M.
When did Cognition Therapeutics Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 7, 2026. It covers the period to June 30, 2026.
Similar companies
Follow CGTX
Get an email when Cognition Therapeutics Inc files with the SEC: results, executive changes, material agreements and annual reports.
Follow CGTX: get an email when it filesWhere the numbers come from
Financial figures are the values Cognition Therapeutics Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.